Crinetics

CRNX

0 Followers

$32.71

+0.03%

$0.01

6 August

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

CRNX Fair Price

$48.00

Overvalued by 90.0%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Crinetics Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutics for the treatment of endocrine and metabolic disorders. The company specializes in discovering and developing new drugs that modulate G-protein-coupled receptors, which are key mechanisms for regulating hormonal signaling in the body. Crinetics focuses on developing treatments for diseases such as acromegaly (caused by excessive growth hormone secretion), Cushing’s disease, and other hormonal disorders. The company's goal is to provide innovative treatment options for patients with these rare conditions.

Feed

There are no posts to show right now.